Table 2.
Characteristics of Cluster groups 1 and 2.
| BClustLong clustering group |
||||
|---|---|---|---|---|
| Cluster 1 | Cluster 2 | p value | ||
| Number of participants | 16 | 6 | N/A | |
| Patient IDs | HC51 | LTBI6 | N/A | |
| HC53 | LTBI10 | |||
| HC54 | LTBI14 | |||
| HC55 | LTBI22 | |||
| LTBI1 | LTBI23 | |||
| LTBI2 | LTBI30 | |||
| LTBI3 | ||||
| LTBI5 | ||||
| LTBI7 | ||||
| LTBI9 | ||||
| LTBI12 | ||||
| LTBI15 | ||||
| LTBI16 | ||||
| LTBI27 | ||||
| LTBI28 | ||||
| Age in years: Median (IQR) | 32.5 (24–41) | 33.5 (29–38) | 0.6 | |
| Gender | Male | 9 (56%) | 4 (66%) | 1 |
| Female | 7 (44%) | 2 (33%) | ||
| Confirmed recent exposure to DS-TBa | Yes | 10 (83%) | 5 (83%) | 1 |
| No | 2 (17%) | 1 (17%) | ||
| BCG | Yes | 10 (62%) | 6 (100%) | 0.2 |
| No | 4(25%) | 0 (0%) | ||
| Unknown | 2 (13%) | 0 (0%) | ||
| Continent of Birth | Africa | 3 (19%) | 1 (17%) | 0.2 |
| Asia | 1 (6%) | 3 (50%) | ||
| Australasia | 1 (6%) | 0 (0%) | ||
| Europe | 9 (56%) | 2 (33%) | ||
| North America | 1(6%) | 0 (0%) | ||
| South America | 1 (6%) | 0 (0%) | ||
| Ethnicity | Asianb | 4 (25%) | 3 (50%) | 0.7 |
| Blackc | 3 (19%) | 1 (17%) | ||
| Whited | 8 (50%) | 2 (33%) | ||
| Othere | 1 (6%) | 0 (0%) | ||
a
For IGRA+ participants only.
b
Includes Bengali, Hong Kong, Kurdish, Sri Lankan, Turkish.
c
Includes Black African.
d
Includes White British, Polish, Romanian, White other.
e
Includes Latin American, Unknown.